目的探讨原发性骨肉瘤手术患者术中输血相关的高危影响因素。方法回顾性分析聊城市中医医院2016年4月—2023年5月收治的108例原发性骨肉瘤手术患者的临床资料。按照术中输血情况分为2组,34例术中输血患者作为输血组,74例术中未输血患者...目的探讨原发性骨肉瘤手术患者术中输血相关的高危影响因素。方法回顾性分析聊城市中医医院2016年4月—2023年5月收治的108例原发性骨肉瘤手术患者的临床资料。按照术中输血情况分为2组,34例术中输血患者作为输血组,74例术中未输血患者作为未输血组。统计患者在围手术期的输血情况,收集患者的一般资料、术前血常规、凝血资料、临床病理资料以及手术相关资料等,先后采取单因素以及多因素logistic回归分析影响原发性骨肉瘤手术患者术中输血相关的高危影响因素。结果输血组的主要输血成分为悬浮红细胞,输入血浆量200~800 mL,平均(456.21±25.14)mL;输血量1~3U,平均(1.36±0.96)U。输血组与未输血组的年龄、身体质量指数(body mass index,BMI)、术前血红蛋白(hemoglobin,Hb)、术前红细胞比容(hematocrit,Hct)、术前血小板(platelet,PLT)、术前凝血酶原国际化标准比值(international normalizedratio,INR)、术前纤维蛋白原(fibrinogen,FIB)值、病史、术前是否接受化疗、手术方式、手术操作时间、手术分级、麻醉分级比较,差异无统计学意义(P>0.05)。输血组与未输血组的性别、发病部位、Huvos分级、切口长度、重建长度、术中出血量比较,差异有统计学意义(P<0.05)。logistic回归分析结果显示,性别、发病部位、Huvos分级、切口长度、重建长度、术中出血量可作为影响原发性骨肉瘤患者术中出血的高危因素(P<0.05)。结论原发性骨肉瘤患者术中输血率相对较高,针对影响术中输血较高的因素进行可靠的早期干预,并制定准确的术前备血计划,在保证手术安全的前提条件下则能够明显降低术中输血率。展开更多
This research shows the current status and the future prospects of green financing in Korea. Green financing is currently on the initial stage in Korea, just like the green growth policy. Thus, banks are contextually ...This research shows the current status and the future prospects of green financing in Korea. Green financing is currently on the initial stage in Korea, just like the green growth policy. Thus, banks are contextually not willing to invest or loan in the green technology or industry for profitability, because the high uncertainty （risk） exists and because Korean people have little concern on green financing, though they have recognized the necessity of green growth. Therefore, the reinforcement of government＇s role is suggested in this research. The public financial agencies are now very important in popularizing the green financing in Korea, and the most effective policy will be the credit guarantee for green technologies or companies provided by public agencies, as shown in the financing policy for the small and middle enterprises. Regarding public efforts, banks should try to perform green financing for both their own profitability and social benefit together with the step-by-step approach, according to the growth stage of green industry and green financing.展开更多
文摘目的探讨原发性骨肉瘤手术患者术中输血相关的高危影响因素。方法回顾性分析聊城市中医医院2016年4月—2023年5月收治的108例原发性骨肉瘤手术患者的临床资料。按照术中输血情况分为2组,34例术中输血患者作为输血组,74例术中未输血患者作为未输血组。统计患者在围手术期的输血情况,收集患者的一般资料、术前血常规、凝血资料、临床病理资料以及手术相关资料等,先后采取单因素以及多因素logistic回归分析影响原发性骨肉瘤手术患者术中输血相关的高危影响因素。结果输血组的主要输血成分为悬浮红细胞,输入血浆量200~800 mL,平均(456.21±25.14)mL;输血量1~3U,平均(1.36±0.96)U。输血组与未输血组的年龄、身体质量指数(body mass index,BMI)、术前血红蛋白(hemoglobin,Hb)、术前红细胞比容(hematocrit,Hct)、术前血小板(platelet,PLT)、术前凝血酶原国际化标准比值(international normalizedratio,INR)、术前纤维蛋白原(fibrinogen,FIB)值、病史、术前是否接受化疗、手术方式、手术操作时间、手术分级、麻醉分级比较,差异无统计学意义(P>0.05)。输血组与未输血组的性别、发病部位、Huvos分级、切口长度、重建长度、术中出血量比较,差异有统计学意义(P<0.05)。logistic回归分析结果显示,性别、发病部位、Huvos分级、切口长度、重建长度、术中出血量可作为影响原发性骨肉瘤患者术中出血的高危因素(P<0.05)。结论原发性骨肉瘤患者术中输血率相对较高,针对影响术中输血较高的因素进行可靠的早期干预,并制定准确的术前备血计划,在保证手术安全的前提条件下则能够明显降低术中输血率。
文摘This research shows the current status and the future prospects of green financing in Korea. Green financing is currently on the initial stage in Korea, just like the green growth policy. Thus, banks are contextually not willing to invest or loan in the green technology or industry for profitability, because the high uncertainty （risk） exists and because Korean people have little concern on green financing, though they have recognized the necessity of green growth. Therefore, the reinforcement of government＇s role is suggested in this research. The public financial agencies are now very important in popularizing the green financing in Korea, and the most effective policy will be the credit guarantee for green technologies or companies provided by public agencies, as shown in the financing policy for the small and middle enterprises. Regarding public efforts, banks should try to perform green financing for both their own profitability and social benefit together with the step-by-step approach, according to the growth stage of green industry and green financing.
